|
Dong
Li Chen, Wei Zhong Wang and Jun Yi Wang Department
of Gastrointestinal Surgery, Xijing Hospital, Fourth Military
Medical University Xi'an
710032, Shaanxi Province, China
Dr. Dong Li Chen, graduated from Fourth Military Medical University
as a postgraduate in 1994, Doctor in charge of General Surgery,
major in nutrition
support and metabolism, having 15 papers published.
Presented at the International Symposium “Growth
Factor and Nutrients
in Intestinal Health and Disease”,
Osaka, Japan, 31 October-3 November, 1998.
Correspondence to: Dr. Dong Li Chen,
Department of Gastrointest
inal Surgery, Xijing Hospital, Fourth Military Medical University Xi'an
710032,
Shaanxi Province, China
Telephone:
0086-29-3375265, Fax. 0086-29-3375261
Email. xjwcwk@fmmu.edu.cn.
Received: 2000-05-18 Accepted: 2000-06-23
Subject
heading: pancreatitis; epidermal
growth factor; parenteral nutrition, total; intestinal mucosa; DNA;
proteins
Chen DL, Wang WZ, Wang JY. Epidermal growth factor prevents gut atro
phy and maintains intestinal integrity in rats with acute
pancreatitis. World J Gastroentero,2000;6(5):762-765
INTRODUCTION
There is abundant evidence that stressful insults such as acute
pancreatitis may
significantly alter the metabolism of the gut mucosa and therefore
its barrier
integrity, resulting in an increase in mucosal permeability and
subsequent trans
location of enteric bacteria and their endotoxins[1-9].
The fact that most bacteria associated with acute pancreatic and
peripancreatic infections are of enteric origin implies that the gut
plays a major role in the pathogenesi
s of pancreatic infection[10-16].Thus various therapeutic
modalities have been undertaken to maintain gut mucosal metabolism
and function as well as to reduce the bacterial translocation during
acute pancreatitis.
In
recent years, much attention has been focused on hormonal regulation
as o
ne of the effective therapeutic strategies. Epidermal growth factor
(EGF), which
presents in large amount in the salivary and Brunner's
gland, and in a variet
y of secretions including saliva and milk, is a potent mitogen for
small intesti
nal cells both in vivo and in vivo. Parenteral
nutrition with administr
ation of exogenous EGF has been shown to increase DNA and protein
content in the small intestine[17-20]. EGF can also
regulate intestinal brush border e
nzymes functionally[21,22].
The
aim of this study is to evaluate the protective effects of EGF on
intesti
nal barrier function in rats with acute pancreatitis under total
parenteral nutr
ition (TPN).
MATERIALS AND METHODS
Materials
Forty-one male Sprague Dawley rats, each weighing
approximately 210g, were purchased from the Experimental Animals
Center of Fourth Military Medical University. The rats were given
water ad libitum and a standard rat food die
t. They were subjected to alternate 12h periods of darkness and
light. Aft
er overnight fasting, the rats underwent placement of a central
venous catheter through a right external jugular vein under sodium
pentobarbital anesthesia (40mg·kg-1,
intraperioneally). The central venous catheters were tunneled
subscutaneously and attached to a spring coil/brass swivel
mechanism, which allowed for free movement of the animals in cages.
Acute pancreatitis was induced by intraductal infusion of 35g·L-1
sodium taurocholate
solution (1.0mL·kg-1)
after clamping the proximal end of the common bile duct and puncture
through the duodenum into the biliary-pancreatic duct[23-27].
On the day of cannulation (d0), rats were randomly divided into one
of the two groups. The control group (n=21)
was fed a conventional parenteral nutrition solution; the EGF group
(n=
20) was fed besides the identical parenteral nutrition formula as in
the control group, EGF (0.1mg·kg-1)
was injected subcutaneously twice
daily.
The
TPN solutions were prepared in a laminar flow hood and were
sterilized by
membrane filtration. The composition of these solutions is shown in
Table 1[28].
Methods
On d 1 and d 5 after induced acute pancreatitis, every 8
animals in each group were anesthetized with 40mg·kg-1
sodium pentobarbital respectively. A midline abdominal incision was
made and a 60cm length of small intestine, 20cm distal from the
ligament of Treitz, was ligated at both ends. Then, 1.0mL
fluorescein isothiocyanate (FITC)-dextran 4000 (25g·L-1)
solution was injected into the lumen of this ligated segment. A
blood sample was withdrawn from the superior mesenteric vein 30min
later for the analysis of plasma FITC-dextran with a fluorescence
spectrophoto
meter at an excitation wave length of 480nm, an emission wave length
of 530nm, and expressed as mg of FITC dextran per L of plasma[29-31]
.
For histologic evaluation, 2cm of
proximal jejunal segement was fixed in 100mL·L-1(V·V-1)
formalin, embedded in paraffin, and stained with hematoxylin-eosin.
Three paraffin sections were prepared from each
fixed
tissue sample, and each slide was analyzed. Villus height and area
were measured
in 10 well orientated villi, giving a total of 30 villis for each
jejunal segme
nt. Measurements were made in a blind fashion on coded slides, and
mean values were obtained[32,33].
Samples of jejunal mucosa were
scraped and used for the measurement of mass a
nd enzyme activity. The activities of sucrase and maltase were
determined by the method of Dahlqvist[34].
Myeloperoxidase (MPO) activity was determin
ed by the method of Bradley et al[35]. The protein
content in each sample was estimated according to the method of Read
et al[36].
Statistical analysis
Data were expressed as x-±s
as indicated in each table. The significance of any difference
between the two groups was determined with the Student's
t test. Differences were considered statistically significant at
P<0.05.
RESULTS
Mortality rate
During the 5d of TPN after induced acute pancreatitis, the
mortality ra
te was similar in the two groups. Specifically, 4.8% (1/21), 23.8%
(4/21) in the control group and 5.0% (1/20), 20.0% (3/20) in EGF
group on d 1 and d 5 respectively. This did not reach statistical
significance.
Changes in body mass
The initial body mass in the two groups was similar (213g±8g
in the EGF group vs 210g±6g
in the control group) and there was no significant change on d1
(214g±9g
in the EGF group vs 211g±6g
in the control group). But the final body mass gain was signifi
cantly greater in the EGF group than in the control group on d5 (15g±
2g in the EGF group vs 4g±1g
in the control group, P<0.
01).
Changes in mucosal wet mass, villus height and area
Mucosal wet mass, villus height and area in the control
group decreased signific
antly as compared with the EGF group on d5 (P<0.01,
Table 2)
.
Changes in intestinal permeability
Plasma FITC-dextran level in the control group increased
significantly as comp
ared with the EGF group on d5(P<0.01,Table
3).
Changes in activities of sucrase, maltase and MPO
Activities of sucrase and maltase in the control group
decreased significantly
as compared with those in the EGF group on d 5(P<0.05,
P<0.01,
respectively). However, MPO activity in the control group increased
s
ignificantly as compared with that in the EGF group on d5 (P<0.01,
Table 4).
Table 1 Composition of TPN solution (mL)
|
Composition
|
Volume
|
|
50%
glucose
|
40
|
|
7%
vamin*
|
16
|
|
20%
intralipid*
|
11
|
|
Addamel*
|
0.3
|
|
Soluvit
N*
|
0.3
|
|
Vitalipid
N adult*
|
0.3
|
|
Heparin
|
60
U
|
*Products
from Kabi Vitrum, Sweden.
Table 2 Changes in mucosal wet mass, villus height and area
(x-±s,
n=8)
|
t/d
|
Group
|
m
(wet mucosa)/mg·cm-1
|
h
(villus)/μm
|
a
(villus)/μm2
|
|
1
|
Control
|
35±3
|
385±32
|
40872±5194
|
|
|
EGF
|
35±4
|
394±37
|
41328±4901
|
|
5
|
Control
|
30±2
|
272±21
|
18658±2469
|
|
|
EGF
|
44±3b
|
409±32b
|
43227±5340b
|
bP<0.01,
vs control group at same time.
Table 3 Changes in plasma FITC-dextran (x-±s,
n=8, mg·L-1)
|
t/d
|
Group
|
FITC-dextran
|
|
1
|
Control
|
1.2±0.5
|
|
|
EGF
|
1.1±0.4
|
|
5
|
Control
|
7.5±0.7
|
|
|
EGF
|
3.3±0.7b
|
bP<0.01,
vs control group at same time.
Table 4 Changes in activities of MPO, sucrase and maltase (x-±s,
n=8)
|
t/d
|
Group
|
z/m
(MPO)/nkat·g-1
|
z/m
(sucrase)/nkat·g-1
|
z/m
(maltase)/nkat·g-1
|
|
1
|
Control
|
143.34±111.67
|
0.54±0.11
|
1.75±0.32
|
|
|
EGF
|
231.19±8.34
|
0.49±0.02
|
1.82±0.21
|
|
5
|
Control
|
96.68±13.35
|
0.19±0.05
|
0.84±0.16
|
|
|
EGF
|
66.71±13.20b
|
0.28±0.08a
|
1.23±0.24b
|
aP<0.05,
bP<0.01
vs control group at same time.
DISCUSSION
The effects of EGF on intestinal integrity were investigated in
an experimental
acute pancreatitis model in rats. TPN was used in both groups to
mimic the clini
cal setting in as much as acute pancreatitis patients are often
nourished by TPN
. Acute pancreatitis can lead to ischemic damage of intestinal
mucosa. Administration of TPN even to healthy experimental animals
is associated with progress
ive intestinal atrophy, which is characterized by reduction of
mucosal mass, vil
lus height and area, mucosal wall thickness, etc[37-41],
so that combination of acute pancreatitis and TPN might lead to more
damage to the gut mucosa than TPN or acute pancreatitis alone. EGF
was selected because it has been suggested to be a potent mitogen
for small intestinal cells both in vitro and in vivo[42-44].
A previous study by our group also demonstrated that EGF could
increase DNA and protein content in the small intestine[45].
In
this study, the body mass gain in the EGF group was significantly
greater
than in the control group on d5. This may be contributed to an
anabolic effect of EGF[44]. On d5, the significantly
increased mucosa
l mass, villus height and area in jejunum were also found in the EGF
group as compared with the control group. This is because that EGF
can enhance intestinal glutam
ine influx and supply more energy for mucosal regeneration so as to
attenuate in
testinal atrophy. And it is also related to the increased mucosal
protein and DN
A content in small intestine[46,47].The results suggest
that the administration of exogenous EGF may prevent intestinal
atrophy in rats with acute pancreatitis under TPN.
For
the assessment of barrier function of intestinal mucosa, a
permeability test
can be a suitable method. Pantzar et al[31]
suggested that nondegr
adable dextrans could be used as permeability markers and reflected
the proteoly
sis-independent passage of proteins through the small intestinal
epithelia. Because there may be a paracellular route through the
tight junctions for the markers with Mr below 30000
instead of a transcellular route as sugg
ested for the larger molecules. In the present study, permeability
of the small intestine to FITC-dextran 4000 (mean Mr,
4000), through the tight
junctions of the intestinal epithelia, increased significantly in
the control group as compared with the EGF group on d 5. The results
indicate that EGF may prevent an increase in permeability of the
small intestine to FITC-dextran 4000 in rats with acute pancreatitis
under TPN.
Tissue
damage can be caused either directly or indirectly by the oxidative
met
abolism of the infiltrating polymorphonuclear leukocytes (PMNs). It
is believed
that after specific membrane perturbation by stimuli, PMNs may
exhibit a burst i
n oxygen consumption and start to generate active oxygen
metabolites, which may
lead to oxidative stress in tissues. So, the accumulation of PMNs in
affected or
gans is considered to be one of the causative factors of multiple
organ failure
(MOF). MPO is an essential enzyme for PMNs function and a useful
indicator of it
s infiltration. Evidence indicates that normal small intestine bears
a low backg
round of MPO activity, and the enzyme activity increased
significantly in ischem
ic small intestine followed by PMNs infiltration[48,49].
MPO activity also increased in the lung of rats with acute
pancreatitis[50,51].It is still unclear whether PMNs
infiltration may be involved in the damage of small intestine in
acute pancreatitis. In the present study, MPO activity in the
control group increased significantly as compared with the EGF group
on d5. It indicates that EGF may reduce PMNs accumulation in
intestinal mucosa, thus minimizing oxidative stress in rats with
acute pancreatitis under TPN.
Sucrase
and maltase, which lie in villus brush border, are two kinds of
impor
tant disaccharidases. They are often used as the markers of the
normal cel
l proliferation and digestive function in small intestine[29,30,34].
In this study, activities of sucrase and maltase in the control
group decreased
significantly compared with the EGF group on d 5. Maintenance of
sucrase and maltase activities indicates that EGF may alleviate
damage of jejunum in rats with acute pancreatitis under TPN.
In
summary, the present study demonstrated that treatment with EGF can
lead to body weight gain, reduce gut atrophy and PMNs accumulation
in intestinal mucos
a, prevent increased intestinal permeability and maintain sucrase
and maltase ac
tivities in acute pancreatitis rats under TPN.
REFERENCES
1 Wang XS, Gao YB, Zhang ZL. Influence of
destroyed pancreatitic cover on mortality of pancreatitis rats.
Shijie
Huaren Xiaohua Zazhi,2000; 8:587-588
2 Gong ZH, Yuan YZ, Lou KX, Tu SP, Zhai ZK, Xu JY.
Effects and mechanisms of somatostatin analogues on apoptosis of
pancreatic
acinar cells in acute pancreatitis in mice.Shijie Huaren Xiaohua
Zazhi,1999;7:964-966
3 Liu Q, Djuricin G, Rossi H, Bewsey K, Nathan C,
Gattuso P, Weinstein RA, Prinz RA. The effect of lexipafant on
bacterial
translocation
in acute necrotizing pancreatitis in rats.Am Surg,1999;65:611-616
4 Kotani J, Usami M, Nomura H, Iso A, Kasahara H,
Kuroda Y, Oyanagi H, Saitoh Y. Enteral nutrition prevents bacterial
translocation
but does not improve survival during acute pancreatitis.Arch
Surg,1999;134:287-292
5 Zhou XZ, Mao QS, Chen YQ, Shen HX. Relationship
between pancreatitis pathology and oxygen free radicals in rats.
Shijie
Huaren Xiaohua Zazhi,2000;8:108 -109
6 Luiten EJ, Hop WC, Endtz HP, Bruining HA.
Prognostic importance of gram negative intestinal colonization
preceding
pancreatic
infection in severe acute pancreatitis. Results of a
controlled clinical trial of selective decontamination.
Intensive
Care Med,1998;24:438-445
7 Wang XD, Andersson R, Soltesz V, Leveau P, Ihse
I. Gut origin sepsis, macroph age function, and oxygen
extraction
associated
with acute pancreatitis in the rat.World J
Surg,1996;20:299-308
8 Wang XP, Yuan YZ, Xu JY. Effect of glutamine on
acute pancreatitis in rats.Xin Xiaohuabingxue Zazhi,1993;1:204-205
9 Liu H, Ji YL. Analysis of 434 cases of acute
pancreatitis.Xin Xiaohuabingxue Zazhi,1996;4:527-528
10 Ruan CP, Wang YH, Wang LG. Bacterial translocation from the
gastrointestinal tract in rats with intestinal ischemia.
Xin
Xiaohuabingxue Za zhi, 1996;4:304-305
11 Wang ZF, Pan CE, Liu SG. Role of inflammatory mediators in
acute pancr eatitis.Huaren Xiaohua Zazhi,1998;6:170-171
12 Gu JC, Qin ZY, Wang Y. Changes of TXA-2 and PGI-2 in acute
necrotic pancreatitis combined with lung injury in
experimental rats.
Shijie Huaren Xiaohua Zazhi,1999;7:275
13 Chen JZ, Dai ZB. Changes of intestinal microcirculation in
acute necrotic pancreatitis with bacterial translocation.
Shijie
Huaren Xiaohua Zazhi, 1999;7:641
14 Li ZL. Diagnosis and treatment of multiple organ disorder
and failure induced by severe infections.
Shijie
Huaren Xiaohua Zazhi,1999;7:1074-1076
15 Sahin M, Yol S, Ciftci E, Baykan M, Ozer S, Akoz M, Yilmaz
O, Kuru C.Does large bowel enema reduce septic
complications in
acute pancreatitis. Am J Surg,1998;176:331-334
16 Dong HL.Intestinal permeability test and its clinical
significance. Shijie Huaren Xiaohua Zazhi,2000;8:562-563
17 Bulus N, Barnard JA. Heparin binding epidermal growth
factor-like growth factor is a transforming growth factor beta
regulated
gene in intestinal epithelial cells.Biochem Biophys Res
Commun,1999;264:808-812
18 Svanberg E, Svaninger G, Soussi B, Lundholm K. Mouse
extensor digitorum longus muscle preparation as a tool in
nutrition research:
a quantitative comp arison to in vivo and cell culture
experiments.Nutrition,1999;15:200-207
19 Petersen H, Haldosen LA. EGF modulates expression of STAT5
in mammary epithelial cells.Exp Cell Res,
1998;243:347-358
20 Usui S.Progress of enteral nutrition.NipponGeka Gakkai
Zasshi,1998;99:154-158
21 Darimont C, Gradoux N, de Pover A. Epidermal growth factor
regulates fatty acid uptake and metabolism in Caco2 cells.
Am
J Physiol,1999;276(3 Pt1):G606-G612
22 Shin CE, Falcone RA Jr, Duane KR, Erwin CR, Warner BW. The
distribution of endogenous epidermal growth factor
after small
bowel resection suggests inc reased intestinal utilization during
adaptation.J Pediatr Surg,1999;34:22-26
23 Plusczyk T, Rathgeb D, Westermann S, Feifel G. Somatostatin
attenuates microcirculatory impairment in acute sodium
taurocholate
induced pancreatitis.Dig Dis Sci,1998;43:575-585
24 Bloechle C, Kusterer K, Kuehn RM, Schneider C, Knoefel WT,
Izbicki JR.Inhibition of bradykinin B2 receptor preserves
microcirculation
in experimental pancreatitis in rats.Am J Physiol,1998;274(1 Pt
1):G42-G51
25 Aho HJ, Koskensalo SML, Nevalainen TJ. Experimental
pancreatitis in the rats: sodium taurocholate-induced acute
pancreatitis.Scand
J Gastroenterol,1980;15:411-416
26 Xu CF, Jiang WP, Cai YL, Zhang YK, Liu SZ. Protective
effect of verapamil on experimental acute pancreatitis.
Xin
Xiaohuabingxue Zazhi,1997 ;5:295-296
27 Lu XD, Liu GS, Chen YR. Experimental and clinical research
of tumor necrosis factor alpha on acute pancreatitis.
Xin
Xiaohuabingxue Zazhi,1997;5:534
28 Zhang GX, Lai JH, Jia TW, Wang WZ, Wang JY. Effect of
epidermal growth factor on glutamine metabolic enzymes in
small intestine
and skeletal muscle of parenterally fed
rats.Nutrition,1997;13:652-655
29 Chen DL, Sando K, Chen K, Wasa M, Takagi Y, Okada A.
Protective effect s of selenium supplementation in minimizing
5 fluorouracil
induced lipid peroxi dative damage of the small intestine.J Trace
Elem Exp Med,1997;10:163-171
30 Chen DL, Wu GS, Wang WZ, Wang JY. Neutrophil infiltration
is involved in 5 fluorouracil induced lipid peroxidative
damage of
the small intestine.Chin Med Sci J,1997;12:181-183
31 Pantzar N, Westrm BR, Luts A, Lundin S. Regional small
intestinal permeability in vitro to different sized dextrans
and
proteins
in the rat. Scand J Gastroenterol,1993;28:205-211
32 Haque SMM, Chen K, Usui N, Iiboshi Y, Okuyama H, Masunari
A, Cui L, Nezu R, Takagi Y, Okada A. Alanyl glutamine
dipeptide supplemented
parenteral nutrition improves intestinal metabolism and prevents
increased permeability in
rats.
Ann Surg,1996;223:334-341
33 Chen DL, Wang WZ, Wang JY. Epidermal growth factor protects
intestinal function of rats with acute pancreatitis
during
total parenteral
nutrition. JPEN J Parenter Enteral Nutr,1999;23:S159
34 Dahlqvist A. Assay of intestinal disaccharidases.Anal
Biochem,1968;22:99-107
35 Bradley PP, Priebat DA, Christensen RD, Rothstein G.
Measurement of cutaneous inflammation: estimation of neutrophil
content
with an enzyme marker. J Invest Dermatol,1982;78:206-209
36 Read SM, Northcote DH. Minimization of variation in the
respose to different proteins of the coomassie blue G dye
binding assay
for protein.Anna Biochem,1981;116:53-64
37 Li J, King BK, Janu PG, Renegar KB, Kudsk KA.
Glycyl-L-glutamine-enr iched total parenteral nutrition maintains
small
intestine gut
associated lymph oid tissue and upper respiratory tract
immunity.JPEN J Parenter Enteral Nutr,
1998;22:31-36
38 Chance WT, Foley NT, Thomas I, Balasubramaniam A.
Prevention of parent eral nutrition induced gut hypoplasia by
coinfusion
of glucagon like peptide 2.Am J Physiol,1997;273(2 Pt 1):G559-G563
39 Janu P, Li J, Renegar KB, Kudsk KA. Recovery of gut
associated lymphoid tissue and upper respiratory tract
immunity
after parenteral
nutrition.Ann Surg,1997;225:707-717
40 Qin HL, Cui HG, Zhang CH, Wu DW, Chu XP. Effects of
glutamine on struc ture and function of gut in endotoxemic rats.
China
Natl J New Gastroenterol,1996;2:69-72
41 Raina N, Cameron RG, Jeejeebhoy KN. Gastrointestinal,
hepatic, and metabolic effects of enteral and parenteral
nutrition
in rats infused with
tumor necrosis factor.JPEN J Parenter Enteral Nutr,1997;21:7-13
42 Goodlad RA, Raja KB, Peters TJ, Wright NA. Effects of
urogastrone epi dermal growth factor on intestinal brush border
enzymes
and mitotic activity. Gut,1991;32:994-998
43 Gong LB, Yang X, Zhang WW, Li SL, Sun SY. Study on the
content of serum epidermal growth factor, gastric acid
secretion and
serum gastrin in duodenitis.China Natl J New
Gastroenterol,1996;2:228-229
44 Zhou J, Wu K, Fernandes CL, Cheng AL, Finch PW.
Keratinocyte growth fa ctor down regulates expression of the
sucrase isomaltase
gene in Caco 2 intestinal epithelial cells.J Biol
Chem,1998;273:33367-33373
45 Wang JY, Zhang LH, Song WL. Epidermal growth factor
regulates intestin al glutamine uptake during total parenteral
nutrition. Clin
Nutr, 1996;15:21-23
46 O'Loughlin
E, Winter M, Shun A, Hardin JA, Gall DG. Structural and function
adapation following jejunal resection in
rabbits: effect
of epidermal growth factor.Gastroenterology,1994;107:87-89
47 Jacobs DO, Evans DA, Mealy K, O'Dwyer
ST, Smith RJ, Wilmore DW. Combined effects of glutamine and
epidermal
growth factor
on the rat intestine.Surgery,1988;104:358-364
48 Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S,
Takeuchi K. Nitric oxide, superoxide radicals and mast cells in
pathogenesis
of indomethacin induced small intestinal lesions in rats.J Physiol
Pharmacol,1999;50:25-38
49 Cetinkale O, Konukoglu D, Senel O, Kemerli GD, Yazar S.
Modulating the functions of neutrophils and lipid peroxidation
by FK506
in a rat model of thermal injury.Burns,1999;25:105-112
50 Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism
of increase d lung injury after acute pancreatitis in IL-10
knockout
mice.J Surg Res,1998;80:110-114
51 Sugita H, Yamaguchi Y, Ikei S, Ogawa M. Effects of
propentofylline on tumor necrosis factor alpha and cytokine-induced
neutrophil
chemoattractant production in rats with cerulein-induced
pancreatitis and ndotoxemia.Pancreas,
97;14:267-275
| |